Skip to main content
Clinical Trials/NCT03652389
NCT03652389CompletedNot Applicable

i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management

NYU Langone Health1 site in 1 country246 target enrollmentStarted: December 18, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
246
Locations
1
Primary Endpoint
HbA1c Level at Baseline

Study Overview

Brief Summary

This study will integrate a technology-based patient-reported outcome (PRO) system [herein MJS DIABETES] that incorporates patients' perspective of their disease and functional status into the management of type 2 diabetes (T2D) in primary care practices. MJS DIABETES is an innovative mobile platform that utilizes text-messaging to capture patients' self-reported PROs in real-time; enhance patient engagement through data-driven feedback and motivational messages; and create dynamic visualizations of the PROs that can be shared in printed reports, and integrated into the EHR; thus making it actionable for patients and their PCPs.

Using a mixed-methods design, this study will be conducted in 2 phases: 1) a formative phase, using the evidence-based user-centered design approach; and 2) a clinical-efficacy phase. For the formative phase, a qualitative research method will be used to: a) adapt MJS to the needs of PCPs and T2D patients; b) integrate MJS DIABETES into the EHR system, the primary care practice and the lives of patients with T2D; and c) evaluate the usability of MJS DIABETES in a subset of T2D patients and their PCPs in order to optimize the tool's performance and workflow integration.

For the clinical efficacy phase, a randomized control trial will be used to identify the efficacy of MJS DIABETES versus Usual Care (UC) on reduction HbA1c at 12-months, among 282 patients with T2D who receive care in safety-net practices.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Primary Care Provider Inclusion Criteria:
  • Fulltime primary care provider (MD/DO, NP) practicing at the participating family health centers (FHCs) and,
  • Provide care to at least five patients with a diagnosis of T2D.
  • Patient Inclusion Criteria:
  • Have a diagnosis of T2D for ≥6 months;
  • Have uncontrolled T2D defined as HbA1c >7% documented in the EHR on at least two visits in the past year;
  • Fluency in English or Spanish;
  • Be willing to send/receive text messages; and

Exclusion Criteria

  • Have a diagnosis of T2D for ≥6 months;
  • Have uncontrolled T2D defined as HbA1c >7% documented in the EHR on at least two visits in the past year;
  • Fluency in English or Spanish;
  • Be willing to send/receive text messages; and

Outcomes

Primary Outcomes

HbA1c Level at Baseline

Time Frame: Baseline

Hemoglobin A1c (HbA1c) extracted from patient medical record. Reported means and 95% confidence intervals are model-adjusted and utilized multiple imputation.

HbA1c Level at Month 12

Time Frame: Month 12

Hemoglobin A1c (HbA1c) extracted from patient medical record. Reported means and 95% confidence intervals are model-adjusted and utilized multiple imputation.

Secondary Outcomes

  • Summary of Diabetes Self-Care Activities (SDSCA): Diet Subscale Score(Month 12)
  • Summary of Diabetes Self-Care Activities (SDSCA): Exercise Subscale Score(Month 12)
  • Summary of Diabetes Self-Care Activities (SDSCA): Blood-Glucose Testing Subscale Score(Month 12)
  • Summary of Diabetes Self-Care Activities (SDSCA): Foot Care Subscale Score(Month 12)
  • Michigan Diabetes Knowledge Scale Score(Month 12)
  • Diabetes Self-Efficacy Scale Score(Month 12)
  • Interpersonal Processes of Care Score Communication Subscale Score(Month 12)
  • Interpersonal Processes of Care: Decision Making Subscale Score(Month 12)
  • Interpersonal Processes of Care: Inter-personal Style Subscale Score(Month 12)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials